NOV Ebit Per Revenue from 2010 to 2024

NOV Stock  USD 14.56  0.26  1.75%   
NOV Ebit Per Revenue yearly trend continues to be fairly stable with very little volatility. Ebit Per Revenue is likely to outpace its year average in 2024. During the period from 2010 to 2024, NOV Ebit Per Revenue regression line of quarterly data had mean square error of  0.02 and geometric mean of  0.07. View All Fundamentals
 
Ebit Per Revenue  
First Reported
2010-12-31
Previous Quarter
0.07584761
Current Value
0.0804
Quarterly Volatility
0.13415172
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NOV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NOV's main balance sheet or income statement drivers, such as Depreciation And Amortization of 369.1 M, Interest Expense of 46.8 M or Total Revenue of 8.8 B, as well as many indicators such as Price To Sales Ratio of 1.49, Dividend Yield of 0.015 or PTB Ratio of 2.1. NOV financial statements analysis is a perfect complement when working with NOV Valuation or Volatility modules.
  
Check out the analysis of NOV Correlation against competitors.

Latest NOV's Ebit Per Revenue Growth Pattern

Below is the plot of the Ebit Per Revenue of NOV Inc over the last few years. It is NOV's Ebit Per Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NOV's overall financial position and show how it may be relating to other accounts over time.
Ebit Per Revenue10 Years Trend
Slightly volatile
   Ebit Per Revenue   
       Timeline  

NOV Ebit Per Revenue Regression Statistics

Arithmetic Mean0.03
Geometric Mean0.07
Coefficient Of Variation505.85
Mean Deviation0.1
Median0.04
Standard Deviation0.13
Sample Variance0.02
Range0.5329
R-Value(0.29)
Mean Square Error0.02
R-Squared0.08
Significance0.30
Slope(0.01)
Total Sum of Squares0.25

NOV Ebit Per Revenue History

2024 0.0804
2023 0.0758
2022 0.0365
2021 -0.0277
2020 -0.0877
2019 -0.054
2018 0.025

About NOV Financial Statements

NOV investors use historical fundamental indicators, such as NOV's Ebit Per Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NOV. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Ebit Per Revenue 0.08  0.08 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NOV Stock Analysis

When running NOV's price analysis, check to measure NOV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NOV is operating at the current time. Most of NOV's value examination focuses on studying past and present price action to predict the probability of NOV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NOV's price. Additionally, you may evaluate how the addition of NOV to your portfolios can decrease your overall portfolio volatility.